Gold star 0.1% 10 ml nasal drops

  • $4.90
Sku: 8618fcc21192
Ingredient: Xylometazoline
The instruction for medical use

of medicine

of the Drop the Gold star

A trade name

of the Drop the Gold star

the International unlicensed

name Xylomethazolinum Form of release

of the Drop nasal 0.05% and 0.1% 10 ml


of 10 ml of drug contain

active agent - xylomethazolinum a hydrochloride of 5.0 mg or 10.0 mg

excipients: sodium dihydrophosphate, sodium hydrophosphate, sodium chloride, a benzalkoniya chloride, water purified.


Transparent colourless liquid.

Pharmacotherapeutic group

of Antikongestanta and other drugs for topical administration.

ATC R01AA07 code

the Pharmacological

Pharmacokinetics At properties topical administration is practically not absorbed, concentration in plasma are so small that they cannot be determined by modern analytical methods.

The pharmacodynamics

the Alpha - an adrenostimulyator, narrows blood vessels of a mucous membrane of a nasal cavity, eliminating hypostasis and hyperaemia of a mucous membrane. Facilitates nasal breath in rhinitises. Action comes in a few minutes and continues within several hours.


- acute allergic rhinitis

- ORZ with the rhinitis phenomena

- sinusitis

- a pollinosis

- average otitis (for reduction of hypostasis of a mucous membrane of a nasopharynx)

- training of the patient for diagnostic manipulations in the nasal courses

the Route of administration and

Intranazalno's doses.

Drops of 0.05%

1 drop contains 0.025 mg of xylomethazolinum of a hydrochloride.

- Children from 2 to 12 years: 2 - 3 drops in each nasal course each 8-10 hours.

Drops 0, 1%

1 drop contains 0.05 mg of xylomethazolinum of a hydrochloride.

- Children are more senior than 12 years and adults: on 2 - 3 drops in each nasal course each 8-10 hours.

Not to use more than 3 times a day.

The course of treatment should not exceed more than 7 days.

Side effects

At frequent and/or prolonged use are possible:

- irritation and or dryness of a mucous membrane of a nasopharynx, burning, pricking, sneezing, hypersecretions.


- a rhinedema

- heartbeat, tachycardia, arrhythmia, increase in arterial blood pressure

- a headache

- vomiting

- insomnia, a depression (at prolonged use of high doses)

- a disorder of vision

At emergence of symptoms to stop use of drug and to see a doctor.


- hypersensitivity to drug

- arterial hypertension, tachycardia

- the profound atherosclerosis

- glaucoma

- atrophic rhinitis

- surgical interventions on a meninx (in the anamnesis)

- a thyrotoxicosis

- pregnancy

- use of monoamine oxidase inhibitors and tricyclic antidepressants

- children's age up to 2 years (for drops of 0.05%)

- children's age up to 12 years (for drops of 0.1%)

not to use Medicinal interactions along with MAO inhibitors and tricyclic antidepressants.

Special indications

of the Drop should not be applied at children 4 months of life are younger.

At children of a younger age group there can come excitement or a sleep disorder. If there come such symptoms, it is necessary to stop intake of medicine.

It is not necessary to use drug at patients with chronic or vasomotorial rhinitis.

To take at an ischemic heart disease (stenocardia), a prostate hyperplasia, diabetes with caution.

Not to use drug more than 7 days.

Pregnancy and the period of a lactation

At pregnancy the administration of drug is contraindicated, in the period of a lactation to take drug with caution.

Feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms

Drug does not reduce ability to run transport and to work with mechanisms.


Symptoms: strengthening of side effects.

Treatment: symptomatic.

A form of release and packing

On 10 ml of drug in a plastic bottle dropper. On a bottle paste the label self-adhesive. On 1 bottle dropper together with the instruction for use in the state and Russian languages place in a pack from cardboard.

To Store storage conditions at a temperature from 15 With up to 25 C.

To store out of children's reach!

Period of storage

3 years.

Not to apply after the expiration date specified on packing.

Prescription status

Without prescription of the doctor.

DANAFA PHARMACEUTICAL DZhOYNT STOCK COMPANY Adres producer: 253, Zung Si St. of Tkhan Tkhe, Tkhan Tkhe's area, Da Nang City, Vietnam

the Address of the organization accepting in the territory of a claim from consumers on quality of products (goods) 142100, Russian Federation, Moscow Region, Podolsk,

Komsomolskaya St., d1
Write a review
Related Products
Dosfarm (Kazakhstan)
Oksivin-DF 0,025% 10ml nasal spray
Avamys® 120 doses Nasal Spray
Glaxo Opereyshens UK Limited (United Kingdom)
Avamys® 120 doses Nasal Spray
$32.00 $40.00
MEDOPTIKA (Kazakhstan)
Glasau-oxy 0.01% 5ml nasal drops
IDA-Pharma (Italy)
Baby Nazol 0.125% 10 ml nasal drops
Jadran Galenski Laboratory (Croatia)
Aqua Maris Norm 50 ml nasal spray
Farmak (Ukraine)
Pharmazolin H 0.1%, 15 ml nasal spray